|
Stock Market
Stock Market Trading
Following a brief wavering on Monday, the market ended in the green on Tuesday, the 26th of March 2024. The tech and conglomerates sectors came through with gains of 0.61% and 0.57% respectively, establishing a robust groundwork for the day's trade.
|
Economy
Gross Domestic Product
The U.S. economy grew at a solid pace during the October-through-December period, led by growth in investments, exports and government spending.
|
Industrial production
|
Producer Price Index
Prices increased on the faster pace again, led by growth in food, materials for manufacturing and crude petroleum prices.
|
|
Management Announcement
Published Thu, Mar 28 2024 9:20 PM UTC
In the ever-evolving landscape of the mining industry, Barrick Gold Corporation has successfully positioned itself as a modern mining business with an exceptional global asset base. Through a strategic merger with Randgold Resources, the company has embarked on a transformational journey, reaffirming its commitment to sustainable growth and value creation. Chairman...
Management Changes
Published Thu, Mar 28 2024 9:00 PM UTC
Furthermore, Nilam Resources has also addressed the current developments regarding its trading status. The company acknowledges its Caveat Emptor status, emphasizing the importance of due diligence for investors. This classification serves as a cautionary note, indicating that there are potential risks associated with investing in Nilam Resources. The company advises in...
|
Announcement
Published Thu, Mar 28 2024 9:01 PM UTC
Aimfinity Investment Corp. I Extends Deadline for Initial Business CombinationAimfinity Investment Corp. I, a Cayman Islands exempted company and special purpose acquisition company (SPAC), has announced its eighth extension of the deadline for completing its initial business combination. The company, listed on Nasdaq under the ticker symbol AIMAU, has extended the deadline ...
|
|
Recently Published News |
Product Service News
Published Thu, Mar 28 2024 8:30 PM UTC
In recent news, Applied Therapeutics, a clinical-stage biopharmaceutical company, announced an update regarding the New Drug Application (NDA) for govorestat (AT-007), a potential treatment for Classic Galactosemia. The U.S. Food and Drug Administration (FDA) has extended the review period for the NDA by three months, setting a new target action date of November 28, 2024. Th...
|
Product Service News
Published Thu, Mar 28 2024 8:30 PM UTC
Par Pacific Holdings Inc (NYSE: PARR) has recently made an encouraging announcement regarding the anticipated repricing and allocation of its existing term loan credit agreement due 2030, known as the Term Loan Facility. The company aims to significantly reduce the Applicable Margin under the loan facility, resulting in a more favorable interest rate structure. Alongside thi...
|
Stock Market Announcement
Published Thu, Mar 28 2024 8:30 PM UTC
Puma Exploration Inc. Successfully Closes Non-Brokered Placement, Securing Funding for Future Projects Byline: Publication:
RIMOUSKI, Québec - Puma Exploration Inc. (TSX-V: PUMA, OTCQB: PUMXF), a leading mineral exploration company, has announced the successful completion of a non-brokered placement, known as the CFT Private Placement. This strategic move ...
|
Clinical Study
Published Thu, Mar 28 2024 8:29 PM UTC
The biopharmaceutical industry continues to be a locus of innovation and progress, with companies reporting encouraging positive strides which directly impact global healthcare. A pivotal actor in this sector is Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical organization. Recently, the company reported its business highlights and financial resul...
|
Product Service News
Published Thu, Mar 28 2024 8:23 PM UTC
Empire State Realty Trust Achieves Global Recognition for Commitment to Health and EquityNew York, NY - Empire State Realty Trust, Inc. (NYSE: ESRT) has recently made waves in the real estate industry by becoming one of the first commercial office and multifamily portfolios in the United States to achieve the prestigious WELL Equity Rating. This remarkable feat was accomplis...
|
Product Service News
Published Thu, Mar 28 2024 8:15 PM UTC
California Water Service Group: A Trustworthy Company Navigating Challenging TimesCalifornia Water Service Group (Group), a leading water utility company, has once again been recognized as one of America's Most Trustworthy Companies by Newsweek magazine. This accolade, awarded for the second consecutive year, highlights the group's commitment to transparency and reliability ...
|
Contract
Published Thu, Mar 28 2024 8:15 PM UTC
Installed Building Products, Inc. (IBP), a leading installer of insulation and related building products, recently announced the successful closure of a new 7-year $500 million term loan. The loan, which has a maturity date of March 28, 2031, carries a BB+ rating by S&P Global Ratings and a Ba1 rating by Moody's Investors Service. The New Term Loan marks a significant develo...
|
Dividend
Published Thu, Mar 28 2024 8:15 PM UTC
In an effort to provide support to its shareholders, Eagle Bancorp, Inc. (NASDAQ: EGBN), the parent company of EagleBank, has announced a cash dividend of $0.45 per share for the first quarter of 2024. This dividend is welcome news for shareholders, especially in light of the recent decline in the company's stock. The cash dividend will be payable on April 30, 2024,...
|
Dividend
Published Thu, Mar 28 2024 8:15 PM UTC
In today's uncertain economic climate, investors are constantly seeking stability and consistency in their portfolios. The First Bancorp (NASDAQ: FNLC), the parent company of First National Bank, stands out as a beacon of strength amidst market volatility. With a proven track record of success and a commitment to delivering value to shareholders, The First Bancorp has once a...
|
Shares
Published Thu, Mar 28 2024 8:15 PM UTC
In a bold move, Ryman Hospitality Properties, Inc. successfully closes $1.0 billion senior notes due 2032, fueling growth and confidence in the market Ryman Hospitality Properties, Inc. recently announced the successful completion of a private placement of $1.0 billion aggregate principal amount of 6.500% senior notes due 2032. The Notes, which are senior unsecured oblig...
|
Clinical Study
Published Thu, Mar 28 2024 8:05 PM UTC
Candel Therapeutics, a clinical stage biopharmaceutical company, recently presented updated data from an ongoing phase 1b clinical trial of their viral immunotherapy candidate, CAN-3110, during the 5th Glioblastoma Drug Development Summit in Boston, Massachusetts. This article aims to ly outline the key facts and implications of the presentation, shedding light on the potent...
|
Business Update
Published Thu, Mar 28 2024 8:05 PM UTC
In the latest financial results and business update, ENDRA Life Sciences Inc., the trailblazer in the Thermo Acoustic Enhanced UltraSound (TAUES) technology, recently released the financial results of the fourth quarter and full December year 2023. The company, which uses the groundbreaking TAUES technology to improve the accessibility, safety, and cost-efficiency of visuali...
|
Management Changes
Published Thu, Mar 28 2024 8:03 PM UTC
EverCommerce Revamps Leadership Team with New Chief Information Officer and Chief People Officer DENVER, March 28, 2024 - EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, has recently announced the addition of two new members to its executive leadership team. With a focus on strengthening its position in the market, the company aim...
|
Clinical Study
Published Thu, Mar 28 2024 8:05 PM UTC
Enliven Therapeutics Presents Exciting Data on Revolutionary Cancer Drug ELVN-001 in Virtual Key Opinion Leader EventBOULDER, Colo., March 28, 2024 - Enliven Therapeutics, Inc. (Nasdaq: ELVN), a leading clinical-stage precision oncology company pioneering the development of next-generation small molecule kinase inhibitors, is thrilled to announce the highly anticipated webca...
|
Dividend
Published Thu, Mar 28 2024 8:05 PM UTC
Atlanta, March 28, 2024 - Acuity Brands, Inc. (NYSE: AYI) has announced the declaration of a quarterly dividend of 15 cents per share, highlighting the company's commitment to rewarding its shareholders. The dividend will be payable on May 1, 2024, to shareholders of record as of April 17, 2024. The decision to declare a dividend reflects Acuity Brands' strong finan...
|
Dividend
Published Thu, Mar 28 2024 8:05 PM UTC
Utz Brands Increases Dividend to Reward Shareholders Amidst Strong Growth HANOVER, Pa. - Utz Brands, Inc. (NYSE: UTZ), a leading manufacturer of branded salty snacks in the United States, has announced a significant increase in its annual dividend. The company's Board of Directors has approved an increase from $0.228 to $0.236 per share, effective immediately. Utz Brands...
|
Shares
Published Thu, Mar 28 2024 8:05 PM UTC
Cartesian Therapeutics Implements Strategic Changes and Grants New Inducement Award Cartesian Therapeutics, a clinical-stage biotechnology company specializing in mRNA cell therapies for autoimmune diseases, has recently announced significant developments within the company. The approval of the conversion of Series A Convertible Preferred Stock and plans to implement a r...
|
|
|
|
News |
Management Announcement
Published Thu, Mar 28 2024 9:20 PM UTC
In the ever-evolving landscape of the mining industry, Barrick Gold Corporation has successfully positioned itself as a modern mining business with an exceptional global asset base. Through a strategic merger with Randgold Resources, the company has embarked on a transformational journey, reaffirming its commitment to sustainable growth and value creation. Chairman...
|
Industrial production
Production by industry
Capacity utilization by industry
|
Stock Market
Stock Market Trading
Following a brief wavering on Monday, the market ended in the green on Tuesday, the 26th of March 2024. The tech and conglomerates sectors came through with gains of 0.61% and 0.57% respectively, establishing a robust groundwork for the day's trade.
|
Stock Market Announcement
Published Thu, Mar 28 2024 8:51 PM UTC
Verve Therapeutics Grants Equity Awards to New Employees in Accordance with Nasdaq Rules BOSTON, March 28, 2024 - Verve Therapeutics, a clinical-stage biotechnology company specializing in gene editing medicines for cardiovascular disease, announced today that it has granted equity awards to six new employees. This action is in line with the company's 2024 Inducement Sto...
|
Product Service News
Published Thu, Mar 28 2024 8:42 PM UTC
Overstock.com Rises Again: Unveiling Crazy Good Deals for Online ShoppersMIDVALE, Utah - In a surprising comeback, e-commerce giant Beyond, Inc. has announced the relaunch of the iconic brand Overstock.com, offering unbeatable deals and discounts across a wide range of products. With a renewed focus on customer experience and sales conversion, the Overstock platform has unde...
|
Product Service News
Published Thu, Mar 28 2024 8:30 PM UTC
In recent news, Applied Therapeutics, a clinical-stage biopharmaceutical company, announced an update regarding the New Drug Application (NDA) for govorestat (AT-007), a potential treatment for Classic Galactosemia. The U.S. Food and Drug Administration (FDA) has extended the review period for the NDA by three months, setting a new target action date of November 28, 2024. Th...
|
Producer Price Index
Prices increased on the faster pace again, led by growth in food, materials for manufacturing and crude petroleum prices.
|
Personal Income and Spending
Consumer spending rose by the smallest amount in three months during January 2024, government data showed, in a further sign of erosion in spending momentum.
|
Auto Sales
|
Product Service News
Published Thu, Mar 28 2024 8:30 PM UTC
Par Pacific Holdings Inc (NYSE: PARR) has recently made an encouraging announcement regarding the anticipated repricing and allocation of its existing term loan credit agreement due 2030, known as the Term Loan Facility. The company aims to significantly reduce the Applicable Margin under the loan facility, resulting in a more favorable interest rate structure. Alongside thi...
|
Stock Market Announcement
Published Thu, Mar 28 2024 8:30 PM UTC
Puma Exploration Inc. Successfully Closes Non-Brokered Placement, Securing Funding for Future Projects Byline: Publication:
RIMOUSKI, Québec - Puma Exploration Inc. (TSX-V: PUMA, OTCQB: PUMXF), a leading mineral exploration company, has announced the successful completion of a non-brokered placement, known as the CFT Private Placement. This strategic move ...
|
Clinical Study
Published Thu, Mar 28 2024 8:29 PM UTC
The biopharmaceutical industry continues to be a locus of innovation and progress, with companies reporting encouraging positive strides which directly impact global healthcare. A pivotal actor in this sector is Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical organization. Recently, the company reported its business highlights and financial resul...
|
Product Service News
Published Thu, Mar 28 2024 8:23 PM UTC
Empire State Realty Trust Achieves Global Recognition for Commitment to Health and EquityNew York, NY - Empire State Realty Trust, Inc. (NYSE: ESRT) has recently made waves in the real estate industry by becoming one of the first commercial office and multifamily portfolios in the United States to achieve the prestigious WELL Equity Rating. This remarkable feat was accomplis...
|
Product Service News
Published Thu, Mar 28 2024 8:15 PM UTC
California Water Service Group: A Trustworthy Company Navigating Challenging TimesCalifornia Water Service Group (Group), a leading water utility company, has once again been recognized as one of America's Most Trustworthy Companies by Newsweek magazine. This accolade, awarded for the second consecutive year, highlights the group's commitment to transparency and reliability ...
|
Contract
Published Thu, Mar 28 2024 8:15 PM UTC
Installed Building Products, Inc. (IBP), a leading installer of insulation and related building products, recently announced the successful closure of a new 7-year $500 million term loan. The loan, which has a maturity date of March 28, 2031, carries a BB+ rating by S&P Global Ratings and a Ba1 rating by Moody's Investors Service. The New Term Loan marks a significant develo...
|
Dividend
Published Thu, Mar 28 2024 8:15 PM UTC
In an effort to provide support to its shareholders, Eagle Bancorp, Inc. (NASDAQ: EGBN), the parent company of EagleBank, has announced a cash dividend of $0.45 per share for the first quarter of 2024. This dividend is welcome news for shareholders, especially in light of the recent decline in the company's stock. The cash dividend will be payable on April 30, 2024,...
|
Dividend
Published Thu, Mar 28 2024 8:15 PM UTC
In today's uncertain economic climate, investors are constantly seeking stability and consistency in their portfolios. The First Bancorp (NASDAQ: FNLC), the parent company of First National Bank, stands out as a beacon of strength amidst market volatility. With a proven track record of success and a commitment to delivering value to shareholders, The First Bancorp has once a...
|
Shares
Published Thu, Mar 28 2024 8:15 PM UTC
In a bold move, Ryman Hospitality Properties, Inc. successfully closes $1.0 billion senior notes due 2032, fueling growth and confidence in the market Ryman Hospitality Properties, Inc. recently announced the successful completion of a private placement of $1.0 billion aggregate principal amount of 6.500% senior notes due 2032. The Notes, which are senior unsecured oblig...
|
Clinical Study
Published Thu, Mar 28 2024 8:05 PM UTC
Candel Therapeutics, a clinical stage biopharmaceutical company, recently presented updated data from an ongoing phase 1b clinical trial of their viral immunotherapy candidate, CAN-3110, during the 5th Glioblastoma Drug Development Summit in Boston, Massachusetts. This article aims to ly outline the key facts and implications of the presentation, shedding light on the potent...
|
Business Update
Published Thu, Mar 28 2024 8:05 PM UTC
In the latest financial results and business update, ENDRA Life Sciences Inc., the trailblazer in the Thermo Acoustic Enhanced UltraSound (TAUES) technology, recently released the financial results of the fourth quarter and full December year 2023. The company, which uses the groundbreaking TAUES technology to improve the accessibility, safety, and cost-efficiency of visuali...
|
Management Changes
Published Thu, Mar 28 2024 8:03 PM UTC
EverCommerce Revamps Leadership Team with New Chief Information Officer and Chief People Officer DENVER, March 28, 2024 - EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, has recently announced the addition of two new members to its executive leadership team. With a focus on strengthening its position in the market, the company aim...
|
Clinical Study
Published Thu, Mar 28 2024 8:05 PM UTC
Enliven Therapeutics Presents Exciting Data on Revolutionary Cancer Drug ELVN-001 in Virtual Key Opinion Leader EventBOULDER, Colo., March 28, 2024 - Enliven Therapeutics, Inc. (Nasdaq: ELVN), a leading clinical-stage precision oncology company pioneering the development of next-generation small molecule kinase inhibitors, is thrilled to announce the highly anticipated webca...
|
Dividend
Published Thu, Mar 28 2024 8:05 PM UTC
Atlanta, March 28, 2024 - Acuity Brands, Inc. (NYSE: AYI) has announced the declaration of a quarterly dividend of 15 cents per share, highlighting the company's commitment to rewarding its shareholders. The dividend will be payable on May 1, 2024, to shareholders of record as of April 17, 2024. The decision to declare a dividend reflects Acuity Brands' strong finan...
|
Dividend
Published Thu, Mar 28 2024 8:05 PM UTC
Utz Brands Increases Dividend to Reward Shareholders Amidst Strong Growth HANOVER, Pa. - Utz Brands, Inc. (NYSE: UTZ), a leading manufacturer of branded salty snacks in the United States, has announced a significant increase in its annual dividend. The company's Board of Directors has approved an increase from $0.228 to $0.236 per share, effective immediately. Utz Brands...
|
Shares
Published Thu, Mar 28 2024 8:05 PM UTC
Cartesian Therapeutics Implements Strategic Changes and Grants New Inducement Award Cartesian Therapeutics, a clinical-stage biotechnology company specializing in mRNA cell therapies for autoimmune diseases, has recently announced significant developments within the company. The approval of the conversion of Series A Convertible Preferred Stock and plans to implement a r...
|
|
|
|
|
|
Events for Thursday, November 14, 2019 |
|
|
|
|
Events for the week starting November 14, 2019 |
|
|
ECONOMIC INDICATORS |
|
FINANCIAL RESULTS | |
|
DIVIDEND PAYOUT |
There are no events for today. |
|
|
|